![]() |
产地 | 进口 |
品牌 | 美国Novabios |
货号 | JL1140 |
保存条件 | 4-30度 |
英文名称 | Chuanglun contraband urine test strip |
CAS编号 | |
保质期 | 2年 |
mob:13802525278 杨qq:506563099 小郑在线
创仑违禁品尿液检测试纸
广州健仑生物科技有限公司
广州健仑生物科技有限公司长期供应:尼古丁检测试剂盒,可替宁检测试剂盒,违禁品检测试剂盒
我司同时提供独立包装试剂盒:bzo-bar-coc--thc -met--opi-oxy-mdma-*- amp-xtc-mtd 或联检试剂盒(胶体金法)
检测范围:*、KET、mamp、MDMA、BZO、THC、*、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。
产品特点:可以根据需求自主订制多联卡。多联卡自由组合,从二联到十五联都可以订制。
产品规格:40t/盒
有效期:2年
保存温度:4-30度
测试前让测试条,尿液样本和/或对照物达到室温(15-30°C)。
1.打开袋子之前将袋子放到室温。 从密封袋中取出试纸并尽快使用。
用箭头指向尿液样本,浸入测试条
2.在尿样中至少10-15秒。 浸泡条时,不要通过测试条上的*线(MAX)。 见下图。
3.将测试条放在不吸水的平面上,启动定时器,等待出现彩色线条。 结果应在5分钟后读取。 10分钟后不要解释结果。
负面:*显示两行。 一条彩色线应该在控制区域(C),另一条明显的彩色线应该在测试区域(T)。 该阴性结果表明*浓度低于可检测水平(1,000 ng / mL)。
*注意:测试线区域(T)的颜色阴影会有所不同,但是每当有微弱的线条时,总是应该将其视为负值。
正面:控制区域(C)出现一条彩色线条。 测试区域(T)不出现任何线条。 该阳性结果表明*浓度超过可检测水平(1,000 ng / mL)。
无效:控制线无法显示。 标本体积不足或不正确的程序技术是控制线失败的最可能的原因。 检查程序并使用新的测试条重复测试。 如果问题仍然存在,请立即停止使用该批次,并联系您当地的经销商。
我司还提供其它进口或国产试剂盒:登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品欢迎致电。创仑违禁品尿液检测试纸
微信二维码扫一扫
【公司名称】 广州健仑生物科技有限公司
杨永汉
【公司
【腾讯 qq 】 506563099 小郑
【公司网址】 www.jianlun。。com
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室
Insulin promotes the uptake and utilization of glucose in body tissues and inhibits the breakdown of glycogen and gluconeogenesis. Therefore, insulin can lower blood glucose. When insulin is secreted too much, the blood glucose drops rapidly, and the brain tissue is most affected. It can cause convulsions, coma and even insulin shock. Conversely, insufficient insulin secretion or lack of insulin receptors often leads to elevated blood glucose; if it exceeds the renal sugar threshold, the sugar is excreted from the urine, causing diabetes; at the same time, due to changes in blood composition (containing excessive glucose), it also leads to high blood pressure, Coronary heart disease and retinal vascular disease and other diseases. Insulin hypoglycemia is the result of many aspects:
(1) Promotion of Target Cell Membranes in Muscle, Adipose Tissue, etc. Carriers transport glucose in the blood into cells.
(2) Covalent modifications enhance phosphodiesterase activity, decrease cAMP levels, and increase cGMP concentrations, thereby increasing glycogen synthase activity, decreasing the phosphorylating enzyme activity, accelerating glycogen synthesis, and inhibiting glycogenolysis.
(3) Activation of pyruvate dehydrogenase by activation of pyruvate dehydrogenase phosphatase accelerates the oxidation of pyruvate to acetyl-CoA and accelerates aerobic oxidation of sugars.
(4) Inhibition of gluconeogenesis by inhibiting the synthesis of PEP carboxykinase and reducing gluconeogenic raw materials.
(5) Inhibiting hormone-sensitive lipase in adipose tissue, slowing down fat mobilization, and increasing glucose utilization in tissues.
Regulating fat metabolism
Insulin can promote the synthesis and storage of fat, so that the blood free fatty acid reduction, while inhibiting the decomposition and oxidation of fat. Insulin deficiency can cause fat metabolism disorders, reduced fat storage, increased decomposition, elevated blood lipids, can cause arteriosclerosis for a long time, leading to serious cardiovascular and cerebrovascular diseases; at the same time, lack of insulin will lead to increased body lipolysis, generate large amounts of ketones Body, ketoacidosis.